Bayer, USAID partner to bring Microgynon® Fe brand to Nigeria


The Bayer Healthcare and United States Agency for International Development USAID has partnered to make Microgynon® Fe Oral Contraceptive available and affordable in Nigeria.

USAID Nigeria’s Director, Health, Population and Nutrition office, Dr. Nancy Lawenthal made this known to Marketing Edge as she emphasized the importance of public-private partnerships in helping governments meet their Millennium Development Goals (MDGs).

She said, “We are pleased that this important initiative between USAID and Bayer Healthcare is being extended to Nigeria. The private sector has an important role to play in contributing to sustainable development and in this case, by ensuring that Nigerian women have access to a sustainable supply of quality, affordable oral contraceptives.”

“Combined oral contraceptives are 99% effective when used consistently and correctly. It also provides women with a reversible method that is easy to discontinue and has a rapid return to fertility. Microgynon® Fe is being used by millions of women around the world and is well known and trusted by medical professionals,” said Dr. O.I. Akinola, Ostetrician/Gynecologist, and President of the OB/GYN Society of Nigeria.

The plan is to make available the oral contraceptive in eleven Sub-Saharan countries by 2016, according to information made available to Marketing Edge.

After the introduction Microgynon® Fe in Ethiopia, Uganda, Tanzania, Malawi, Rwanda, Ghana, and Kenya, the Bayer-USAID partnership will expand the initiative to several more Sub-Saharan countries by 2016. The product comes as a result of an innovative public-private partnership between Bayer HealthCare and the United States Agency for International Development (USAID).

Microgynon® Fe brand is the world’s most widely used oral contraceptive and there is plan to make the contraceptive available at reduced price to enable middle-income couples to access a quality, affordable family planning product.

The partnership is designed to make more affordable family planning choices available to women through the private sector and address the growing demand for contraceptives and the overall sustainability of supply.

Family planning allows couples to plan their families as they desire, reduces the risks from unintended and/or high-risk pregnancies, and improves the health of mothers and their children by allowing time between pregnancies.

Microgynon® Fe is manufactured in Germany by Bayer HealthCare and imported to Nigeria by CHI Pharmaceuticals.


Leave a Reply

Your email address will not be published. Required fields are marked *


    No comments found.